Evidence map›Paper›PMID 39943872›Full record

ArticleMicrobial genomics2025

Evaluating methods for genome sequencing of

Karina Andrea Büttner, Vera Bregy, Fanny Wegner, Srinithi Purushothaman, Frank Imkamp, Tim Roloff Handschin, Mirja H Puolakkainen, Eija Hiltunen-Back, Domnique Braun, Ibrahim Kisakesen and 10 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbial genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Current status and future directions ofFrontiers in veterinary science · 2026
    Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Novel features ofMicrobial genomics · 2026
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Karina Andrea BüttnerUniversidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Departamento de Bioquímica Clínica, Cátedra de Microbiología Clínica, Buenos Aires, Argentina.
Vera BregyInstitute of Medical Microbiology, University of Zürich, Zurich, Switzerland.
Fanny WegnerInstitute of Medical Microbiology, University of Zürich, Zurich, Switzerland.
Srinithi PurushothamanInstitute of Medical Microbiology, University of Zürich, Zurich, Switzerland.
Frank ImkampInstitute of Medical Microbiology, University of Zürich, Zurich, Switzerland.
Tim Roloff HandschinInstitute of Medical Microbiology, University of Zürich, Zurich, Switzerland.
Mirja H PuolakkainenMember of the ESCMID Study Group on Mycoplasma and Chlamydia (ESGMAC), Basel, Switzerland.
Eija Hiltunen-BackDepartment of Dermatology and Allergology, University of Helsinki and HUS Helsinki University Hospital, Helsinki, Finland.
Domnique BraunDepartment of Infectious Diseases, University Hospital Zürich, University of Zurich, Zürich, Switzerland.
Ibrahim KisakesenLife Sciences and Diagnostic Group, Agilent Technologies France, Les Ulis, France.
Andreas SchreiberLife Sciences and Diagnostic Group, Agilent Technologies France, Les Ulis, France.
Andrea Carolina EntrocassiUniversidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Departamento de Bioquímica Clínica, Cátedra de Microbiología Clínica, Buenos Aires, Argentina.
María Lucía Gallo VauletUniversidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Departamento de Bioquímica Clínica, Cátedra de Microbiología Clínica, Buenos Aires, Argentina.
Deysi López AquinoDivisión Cirugía, Hospital Fernández, Buenos Aires, Argentina.
Laura Svidler LópezDivisión Cirugía, Hospital Fernández, Buenos Aires, Argentina.
Luciana La RosaCentro Privado de Cirugía y Coloproctología, Buenos Aires, Argentina.
Adrian EgliInstitute of Medical Microbiology, University of Zürich, Zurich, Switzerland.
Marcelo Rodríguez FermepinUniversidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Departamento de Bioquímica Clínica, Cátedra de Microbiología Clínica, Buenos Aires, Argentina.
Helena Mb Seth-SmithMember of the ESCMID Study Group on Mycoplasma and Chlamydia (ESGMAC), Basel, Switzerland.
On Behalf Of The Escmid Study Group For Mycoplasma And Chlamydia Infections Esgmac

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rates of bacterial sexually transmitted infections (STIs) are rising, and accessing their genomes provides information on strain evolution, circulating strains and encoded antimicrobial resistance (AMR). Notable pathogens include

Indexed as

Chlamydia trachomatisGenome, BacterialSexually Transmitted Diseases, BacterialWhole Genome SequencingArgentinaChlamydia InfectionsDNA, BacterialHigh-Throughput Nucleotide SequencingHumansNeisseria gonorrhoeaeSwitzerlandTreponema pallidumDNA, Bacterialhybridization captureMycoplasma genitaliumnanopore adaptive samplingNeisseria gonorrhoeaetarget enrichmentTreponema pallidum

Identifiers

PMID39943872
PMCPMC12282229

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.